
ScriptCo
OperatingScriptCo Inc.
Healthcare · Woodway, TX · Founded 2019
Medications at our cost-zero markeup
Financials
FY2020–FY2022 · from SEC filings · hover any figure for its sourceFigures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Pre-money — the valuation set before each round’s money came inBlue bars are the pre-money valuation the company stated for a priced round.
Fundraising history
Team
5 people
Mark attended Baylor University from 2002-2005. In 2005 Mark left Baylor after being selected in the first round of the MLB draft by the St. Louis Cardinals. After leaving professional baseball in 2009, Mark began his career in the healthcare space as a sales representative for Stryker Orthopedics, wherein his first year, he was a top 3 finalist for “rookie of the year” nationally. After 3+ years of growing the start-up territory, Mark’s entrepreneurial spirit led him to start his own company marketing DME and pharmaceuticals, building a start-up territory. In 2016 Mark and Zach Zeller co-founded three pharmacies located in Texas. Through owning and operating these pharmacies Mark has vast experience in navigating the pharmacy space and has shown exceptional abilities to grow and manage pharmacies. Mark has designed, managed, and implemented pharmacy workflow from the ground up for the 3 pharmacies in Texas that he Co-Founded in 2016. Marks leadership grew these pharmacies from start-up to $2,450,000+ in EBITDA in two years with two physical locations and one operation center. The pharmacy’s goal was to offer traditional medications as well as topically based treatment modalities while driving down patient cost giving more access to nontraditional treatment modalities that were better than the status quo. In mid-2019 Mark and Zach Zeller founded ScriptCo, the first pharmacy in America to sell medications at cost in an effort to solve this massive issue. In early 2021 Mark was added to the Forbes Next 1000 CEO’s list. https://www.forbes.com/profile/mark-mccormick/?sh=76e02964679a Mark has been Married for 16 years and has 2 children. Mark works 40 hours per week for ScriptCo.

Sam has been a registered pharmacist in Texas since 2004. He is an Infusion, Accreditation, and Compliance Specialist. He has a Master’s degree in Pharmacy Administration and Outcomes Research. Sam was one of the “40 Pharmacist under 40 in Texas” recognized by the Texas Pharmacy Association at their 2005 Annual meeting for his contributions to HIV research and community practice. Sam has maintained teaching relationships with several institutions over the years, including The University of Houston, The University of Phoenix, and The University of Mumbai. Sam has founded/acquired several companies over the last decade and made several successful exits. He currently consults with several nationally and internationally recognized companies in matters specifically dealing with strategic acquisitions, compliance, and healthcare. Sam works 2 hours per week for ScriptCo.

After graduating from The University of Texas at Austin as a student-athlete competing in Track and Field, setting a school record, becoming an All American, and multiple time Big 12 champion, Zach went directly into medical device sales. Zach was in the operating room for more than nine years and was nationally recognized by two different multi-billion-dollar orthopedic companies. After deciding to move out of the surgical space and into the pharmacy space Zach and Mark McCormick co-founded three pharmacies located in Texas. Zach helped grow the company from start-up to $2,450,000 in EBITDA in two years with two physical locations and one operation center. The pharmacy’s goal was to offer traditional medications as well as topically based treatment modalities all while driving down patient cost giving more access to traditional and nontraditional treatment modalities that were better than the status quo. In mid-2019 Mark and Zach Zeller founded ScriptCo, the first pharmacy in America to sell medications at cost in an effort to solve this massive issue. Zach has been married for 16 years and has 3 children. Zach works 40 hours per week for ScriptCo.

JJ is Managing Director at Blue Collective, a Venture Capital investment firm located in Brooklyn, NY. Blue Collective has $100 MM in assets under management and invests exclusively in super early-stage startups across the industry founded by phenomenal entrepreneurs. Prior to founding Blue, JJ was a Restructuring executive and a Partner at McKinsey & Company, where he was a leader in the Private Equity practice. John works 4 hours per month for ScriptCo.
Names and titles as disclosed on SEC Form C, StartEngine. Bios and photos come from the platform campaign page and may be out of date.
Reg CF annual-report compliance
Filed 1 of 4 annual reports (FY2022–FY2025)
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.